UK markets closed

Everest Re Group, Ltd. (0U96.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
255.52+2.68 (+1.06%)
At close: 04:02PM BST

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • d
    dujon
    I don't think that RE has another 10% in gains in it. Looks pretty bad here. I actually found (http://Achieverspot.tech) the other day and their stocks are way better...
  • C
    CIANCIARULO
    I am sick of all the spam on yahoo! I actually try to stay off of the RE message board now and exclusively use (http://Themaxgains.tech)
  • O
    Owen
    Just saw RE published on the daily alert watchlist at (http://market-engross.club)
  • 1
    100M
    Too cheap here imo
  • T
    TOM
    They've got exclusion for the virus on 90% of their contracts. Listen to the last CC. Long and strong!
  • G
    GG
    Let’s get to 300
  • A
    Apollo
    How much would mortgage defaults impact this stock?
  • k
    kevin w
    saw this in Eisai news feed. pretty amazing to remove all plaques in a year. does this "cure" AZ, I dunno.

    Eisai Co., Ltd. (Pink: ESALY) and Biogen, Inc. (NASDAQ: BIIB) announced results of new clinical, biomarker and safety assessments of brain amyloid reduction and five-year clinical status of people living with early Alzheimer's disease from the lecanemab Phase 2b 201 and the open-label extension studies.

    The findings, presented in a late-breaking roundtable session with clinical researchers at the 2021 Clinical Trials on Alzheimer's Disease conference, showed treatment with lecanemab resulted in reduction of brain amyloid levels in as early as three months and robust clearance of amyloid plaque with more than 80% of participants achieving amyloid negative status by 12-18 months of treatment as measured by PET.
  • p
    precisionvision
    Liking this partial recovery
  • G
    GG
    52 week high. Can we see
  • E
    Eddy
    Expensive, dividend is too large given the circumstances with cash flow
  • Y
    Yahoo Finance Insights
    RE is up 4.91% to 250.74
  • Y
    Yahoo Finance Insights
    RE is up 4.98% to 236.66
  • Y
    Yahoo Finance Insights
    RE is up 4.98% to 235.79
  • A
    Anonymous
    ObamaCare enrollment strong in third week of sign-ups
    remember when the donald promised? lolz!
  • Y
    Yahoo Finance Insights
    RE is down -4.92% to 222.78
  • Y
    Yahoo Finance Insights
    RE is up 5.51% to $217.83
  • Y
    Yahoo Finance Insights
    RE reached an all time high at 289.00
  • Y
    Yahoo Finance Insights
    RE reached a 52 Week low at $201.85
  • Y
    Yahoo Finance Insights
    RE is down 5.00% to $218.03